| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5697687 | Cancer Treatment Reviews | 2017 | 8 Pages |
Abstract
New-generation therapies in mRCC should demonstrate a gain not only in survival but also in QoL to be included in the therapeutic arsenal.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
M. Dos Santos, P.E. Brachet, C. Chevreau, F. Joly,